- CLDX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Celldex Therapeutics (CLDX) 10-K/A2015 FY Annual report (amended)
Filed: 25 Feb 16, 12:00am
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (Nos. 333-205694, 333-182142, 333-189336, 333- 151728 and 333-117602) and on Form S-3 (No. 333-192640) of Celldex Therapeutics, Inc. of our report dated February 25, 2016 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K/A.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 25, 2016
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.